Exploited in the wild

CVE-2026-123218: IBM Aspera Faspex Admin Privilege Escalation

Inttelio Threat Feeds ·

CVE-2026-123218 is an incorrect authorization flaw (CWE-863) in IBM Aspera Faspex 5.0.0 through 5.0.19. A crafted message can bypass user authorization and give the sender full administrative privileges. CISA added it to its Known Exploited Vulnerabilities (KEV) catalog on 2026-11-09, so it has been exploited in the wild.

CVECVE-2026-123218
Vendor / productIBM Aspera Faspex
CVSS v3.19.8 CRITICAL
WeaknessCWE-863
Exploited in the wildYes - added to CISA KEV November 9, 2026
CISA due date (federal agencies)November 12, 2026
PublishedNovember 7, 2026

Who is affected

Organizations running IBM Aspera Faspex versions 5.0.0 through 5.0.19. The fixed version is not stated in the source data, so check IBM's advisory (https://www.ibm.com/support/pages/node/7295921) for the patched release and remediation instructions. Faspex is a file exchange platform and is often exposed to the internet for external partners, which raises the risk.

What attackers can do

An attacker can send a specially crafted message that bypasses authorization checks and gives them full administrative control of the Faspex instance. The NVD and CISA descriptions say an authorized or authenticated user is needed, but IBM's CVSS 3.1 score (9.8, Critical) lists no privileges required, network attack vector, low complexity and no user interaction. Treat it as potentially exploitable without valid credentials until IBM clarifies. With admin access, an attacker could fully compromise the confidentiality, integrity and availability of the system and the files it handles.

Exploitation status

Exploited in the wild. CISA added CVE-2026-123218 to the KEV catalog on 2026-11-09 with a due date of 2026-11-12. That due date binds U.S. federal civilian agencies under BOD 26-04. Other organizations should read the short deadline as a sign of urgency. CISA has flagged the entry for forensic triage. Use in ransomware campaigns is listed as Unknown. The source data does not include indicators of compromise or threat actor details.

What to do now

  1. Inventory all IBM Aspera Faspex instances, including cloud-hosted and test systems, and record their versions. Any version from 5.0.0 through 5.0.19 is affected.
  2. Note which instances are reachable from the internet and prioritize those first.
  3. Apply the update or mitigations in IBM's advisory (https://www.ibm.com/support/pages/node/7295921). The fixed version is not stated in the source data, so confirm it there.
  4. If you cannot apply a fix or mitigation right away, restrict network access to Faspex or take it offline. CISA's guidance is to stop using the product if mitigations are unavailable.
  5. Check for compromise, because the flaw is known to be exploited and CISA flagged it for forensic triage. Review admin account lists, recent privilege changes, new or modified users, configuration changes, and file access or transfer logs for unexpected activity. Do this before and after patching. Federal agencies should follow CISA's BOD 26-04 Forensics Triage Requirements.
  6. If you find signs of compromise, rotate credentials and secrets stored in or used by Faspex, preserve logs, and start your incident response process.
  7. Aim to finish remediation by the KEV due date of 2026-11-12 even if you are not a federal agency.

Frequently asked questions

Which versions of IBM Aspera Faspex are affected by CVE-2026-123218?

IBM Aspera Faspex 5.0.0 through 5.0.19 are affected. The source data does not state the fixed version. See IBM's advisory at https://www.ibm.com/support/pages/node/7295921.

Is CVE-2026-123218 being actively exploited?

Yes. CISA added it to the Known Exploited Vulnerabilities catalog on 2026-11-09, which means there is evidence of exploitation in the wild. Whether it has been used in ransomware campaigns is listed as Unknown.

Does an attacker need an account to exploit CVE-2026-123218?

The sources disagree. The NVD and CISA descriptions refer to an authorized or authenticated user crafting a message. IBM's CVSS 3.1 vector (9.8 Critical) lists no privileges required. Until IBM clarifies, assume it may be exploitable without credentials, and patch or restrict access quickly.

Sources

This briefing was drafted with AI from the official NVD and CISA records. Always confirm affected versions and fixes in the vendor advisory.

Not sure if you are exposed?

Our penetration testers find exploitable flaws before attackers do, and a vCISO can run your vulnerability program.

Talk to Inttelio